BPC Stock Overview
Birzeit Pharmaceuticals Company manufactures and markets generic medicines in the Palestinian Authority.
Birzeit Pharmaceuticals Company Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$4.00|
|52 Week High||US$4.10|
|52 Week Low||US$2.64|
|1 Month Change||1.27%|
|3 Month Change||0.76%|
|1 Year Change||50.66%|
|3 Year Change||55.43%|
|5 Year Change||65.95%|
|Change since IPO||213.97%|
Recent News & Updates
|BPC||PS Pharmaceuticals||PS Market|
Return vs Industry: BPC exceeded the PS Pharmaceuticals industry which returned -17.4% over the past year.
Return vs Market: BPC exceeded the PS Market which returned 7.3% over the past year.
|BPC Average Weekly Movement||2.7%|
|Pharmaceuticals Industry Average Movement||4.8%|
|Market Average Movement||2.7%|
|10% most volatile stocks in PS Market||5.6%|
|10% least volatile stocks in PS Market||1.3%|
Stable Share Price: BPC is not significantly more volatile than the rest of PS stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: BPC's weekly volatility (3%) has been stable over the past year.
About the Company
|1974||n/a||Talal Kadhim Nasereddin||https://www.bpc.ps|
Birzeit Pharmaceuticals Company manufactures and markets generic medicines in the Palestinian Authority. It offers its products in various therapeutic fields comprising alimentary system, cardio-vascular system, muscolo-skeletal system, endocrines, central nervous system, genito-urinary system, obstetrics and gynecology, infections, dermatological preparations, ophthalmic drugs, respiratory system, and nutrition and metabolism, as well as ear, nose, and oropharynx. The company provides its products in various dosage forms, including ampoules, capsules, tablets and caplets, syrups, suspensions and granules, ophthalmic, semi-solids, powder vials, suppositories, and powders.
Birzeit Pharmaceuticals Company Fundamentals Summary
|BPC fundamental statistics|
Is BPC overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|BPC income statement (TTM)|
|Cost of Revenue||US$29.16m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.30|
|Net Profit Margin||24.34%|
How did BPC perform over the long term?See historical performance and comparison